Danaher Co. (NYSE:DHR) Shares Sold by Foster & Motley Inc.

Foster & Motley Inc. cut its stake in Danaher Co. (NYSE:DHR) by 23.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 950 shares of the conglomerate’s stock after selling 287 shares during the quarter. Foster & Motley Inc.’s holdings in Danaher were worth $264,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. nVerses Capital LLC acquired a new stake in shares of Danaher in the 2nd quarter worth $25,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher in the 2nd quarter worth $25,000. MFA Wealth Advisors LLC acquired a new stake in shares of Danaher in the 2nd quarter worth $51,000. Financial Connections Group Inc. acquired a new stake in shares of Danaher in the 2nd quarter worth $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher in the 1st quarter worth $55,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 10.90% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. Bank of America increased their price target on Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. The Goldman Sachs Group increased their price target on Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. KeyCorp increased their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, TD Cowen raised their target price on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Price Performance

Shares of NYSE DHR opened at $246.10 on Friday. The firm has a market capitalization of $177.75 billion, a PE ratio of 46.97, a price-to-earnings-growth ratio of 4.54 and a beta of 0.85. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70. The stock’s 50-day simple moving average is $265.79 and its 200-day simple moving average is $260.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.02 earnings per share. As a group, equities research analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.